Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387907
Status:
COMPLETED
Last Update Posted:
2016-05-05
First Post:
2006-10-12
Brief Title:
Study of Larotaxel in Combination With Weekly Herceptin in Patients With HER2 Positive Metastatic Breast Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
TCD10037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None